Oracle Investment Management as of June 30, 2020
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 16 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Quidel Corporation | 63.3 | $449M | 2.0M | 223.74 | |
| Biohaven Pharmaceutical Holding Call Option | 11.6 | $82M | 2.1M | 39.52 | |
| Opko Health (OPK) | 5.8 | $41M | 12M | 3.41 | |
| Aspira Womens Health | 5.6 | $40M | 10M | 3.84 | |
| Agenus Com New (AGEN) | 3.7 | $26M | 6.7M | 3.93 | |
| Accelr8 Technology Call Option | 2.9 | $21M | 4.2M | 4.97 | |
| Amarin Corp Spons Adr New (AMRN) | 2.1 | $15M | 2.2M | 6.92 | |
| BioCryst Pharmaceuticals (BCRX) | 1.3 | $9.5M | 2.0M | 4.76 | |
| Soleno Therapeutics Com New | 1.1 | $8.1M | 3.7M | 2.22 | |
| Motus Gi Hldgs Incorporated | 0.7 | $5.0M | 3.8M | 1.32 | |
| Antares Pharma | 0.7 | $4.7M | 1.7M | 2.75 | |
| Pacific Biosciences of California (PACB) | 0.6 | $4.6M | 1.3M | 3.45 | |
| Y Mabs Therapeutics (YMAB) | 0.2 | $1.1M | 25k | 43.19 | |
| Biolase Com New | 0.1 | $1000k | 1.7M | 0.57 | |
| Biogen Idec (BIIB) | 0.1 | $987k | 3.7k | 267.62 | |
| Contrafect Corp Com New | 0.1 | $823k | 129k | 6.39 |
